Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

EyePoint Pharmaceuticals Inc. buy Cantor Fitzgerald

EyePoint Pharmaceuticals Inc.
Start price
€12.20
08.07.26 / 50%
Target price
€41.17
08.07.27
Performance (%)
6.56%
Price
€12.50
13.07.26
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald shows slight gains of 6.56%. This prediction currently runs until 08.07.27. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this prediction
Performance without dividends (%)
Name 1w
EyePoint Pharmaceuticals Inc. 6.56%
iShares Core DAX® -3.173%
iShares Nasdaq 100 -1.006%
iShares Nikkei 225® -3.600%
iShares S&P 500 0.214%

Comments by Cantor_Fitzgerald for this prediction

In the thread EyePoint Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 6.56%
Target price 41.167
Change
Ends at 08.07.27

Eyepoint Pharmaceuticals (EYPT) had its "overweight" rating reaffirmed by Cantor Fitzgerald. They now have a $47.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat

Cantor Fitzgerald 
0
Report Share
08.07.26

Stopped prediction by Cantor_Fitzgerald for EyePoint Pharmaceuticals Inc.

buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.48
20.06.24
-
20.06.25
-6.79%
21.06.25

Cantor Fitzgerald 
20.06.24 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€10.20
14.09.23
€29.02
14.09.24
-18.55%
15.09.24

Cantor Fitzgerald 
14.09.23 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€9.00
31.08.23
€28.59
31.08.24
-13.24%
01.09.24

Cantor Fitzgerald 
31.08.23 50%